Approval · Notice of Compliance 9169 · 2007
GLUDEF: Notice of Compliance 9169
Issued November 14, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9169
- Date
- November 14, 2007
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Diagnostic radiopharmaceutical
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GLUDEF | Not yet assigned | — |
Medicinal ingredients
- FLUDEOXYGLUCOSE 18F 11,420 MBQ per 5ML
- FLUDEOXYGLUCOSE 18F 90,000 MBQ per 20ML